Lundbeck silent on shutdown of Indian operations

Despite a complete withdrawal from the market of one of the world's most populous nations, the Danish pharmaceutical giant doesn't want to comment on the reason why, or whether any other domestic operations are facing closedowns.
Lundbeck's interest in the Indian market has suffered a blow, but the company doesn't want to say why it is suddenly ceasing operations completely. | Photo: Foto af Ulrich Quistgaard
Lundbeck's interest in the Indian market has suffered a blow, but the company doesn't want to say why it is suddenly ceasing operations completely. | Photo: Foto af Ulrich Quistgaard
BY ULRICH QUISTGAARD, TRANSLATED BY DANIEL PEDERSEN

With over 1.3 billion people, India should, on the face of it, appear an attractive drug market for life science firms. Nonetheless, Lundbeck has decided to cease its operations in the Central Asian country completely.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading